enVVeno Medical Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

Ended the Year With $55 Million in Cash Expected To Fund Operations Through the End of 2024 Including Release of Topline Pivotal Trial DataNine (9) VenoValve Surgeries Successfully Completed and 16 Clinical Sites Currently Active in Ongoing SAVVE …